NICE (UK National Institute for Clinical Excellence) boosts capacity ahead of new, enlarged agenda
This article was originally published in Clinica
The UK's Department of Health (DoH) has announced the technologies it will next submit to the National Institute for Clinical Excellence (NICE), subject to consultation with key stakeholders. Meanwhile, NICE has amended its appraisals process and is strengthening its capacity, ahead of a possible doubling of its workload.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.